Analytical Method Development for Tablets of the New Kappa-Opioid Agonist RU-1205
An analytical method for tablets of the new imidazobenzimidazole kappa-opioid agonist RU-1205 was developed. The principal pharmacopoeial parameters of tablet quality were studied. The contents of impurities and RU-1205 in the tablets were assayed quantitatively using HPLC. A method for determining the dose uniformity using UV spectrophotometry was developed. Procedures were proposed for determining the authenticity and dissolution profile of RU-1205 tablets.
KeywordsRU-1205 tablets pharmaceutical analysis analytical method HPLC UV spectrophotometry impurities quantitative determination dose uniformity dissolution test
- 1.A. A. Spasov, V. A. Anisimova, P. M. Vasil’ev, et al., “Kappa-opioid agonist,” RU Pat. 2,413,512, Mar. 10, 2011; Byull. Izobret., No. 7 (2011).Google Scholar
- 2.A. A. Illarionov, L. N. Grushevskaya, and L. M. Gaevaya, Khim.-farm. Zh., 48(5), 50 – 56 (2014).Google Scholar
- 3.USSR State Pharmacopoeia. XIth Ed., Meditsina, Moscow, 1990, p. 154.Google Scholar